Last reviewed · How we verify

NCT03182452

Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (Europe)

Completed Last updated 9 April 2018
What this trial tests

trial testing Alarm Advisor in Clinical Alarms in 1,487 participants. Completed in 15 January 2018.

Timeline
15 May 2017
Primary endpoint
15 January 2018
15 January 2018

Quick facts

Lead sponsorPhilips Healthcare
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,487
Start date15 May 2017
Primary completion15 January 2018
Estimated completion15 January 2018
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Philips Healthcare — full company profile →

Who can join

18 and older, any sex, with Clinical Alarms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This Clinical Study will be conducted as a comparative study focusing on usability and efficiency by comparing alarm burden pre- and post-implementation of an "Alarm Advisor software".

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Clinical Alarms

Currently open trials in the same condition.

Other Philips Healthcare trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03182452.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing